The Indigenous Smoking Crisis: Colonialism, Tobacco, and Health Justice

Among the Lakota, tobacco is sacred—a gift from the Creator, used in ceremony, prayer, and healing for thousands of years before European contact. The commercial tobacco sold in convenience stores on the Pine Ridge Reservation, where smoking rates exceed 50%, is not that tobacco. It's a mass-produced, chemically engineered, lethally addictive product whose global spread is inseparable from the colonial project that dispossessed the Lakota of their land, their sovereignty, and their health. The distinction between sacred tobacco and commercial tobacco is central to indigenous health advocacy, and it's largely invisible in mainstream tobacco control discourse. Indigenous peoples worldwide smoke at rates two to four times those of settler populations, suffer disproportionately from smoking-related disease, and have been systematically targeted by the tobacco industry for decades. Addressing the indigenous smoking crisis requires understanding tobacco not just as a public health problem but as a colonial one.

The epidemiology is stark and consistent across settler-colonial states. In Canada, First Nations adults smoke at roughly three times the rate of the general population. In Australia, Aboriginal and Torres Strait Islander peoples smoke at nearly three times the rate of non-Indigenous Australians. In New Zealand, Māori smoking rates, while declining, remain roughly double those of non-Māori. In the United States, American Indian and Alaska Native adults have the highest smoking prevalence of any racial or ethnic group. These disparities persist after controlling for income, education, and healthcare access—meaning they're not reducible to socioeconomic factors alone. The residual disparity reflects the specific historical relationship between indigenous communities and commercial tobacco: a history that includes the use of tobacco as a trade good and currency during colonization, the establishment of tobacco as a cash crop on dispossessed indigenous lands, and decades of targeted marketing by an industry that identified indigenous communities as growth markets and tailored its advertising accordingly.

The tobacco industry's targeting of indigenous communities is documented in internal industry records and consistent across countries. In Canada, tobacco companies sponsored powwows, rodeos, and cultural events on reserves, distributing free cigarettes and building brand loyalty through association with cultural identity. In the United States, the industry developed 'All Natural' cigarette brands (Natural American Spirit) that appropriated indigenous imagery and the concept of 'natural tobacco' while selling a product that was chemically indistinguishable from conventional cigarettes and just as deadly. In New Zealand, the industry cultivated relationships with Māori leaders and framed tobacco taxation as discriminatory, positioning itself as an ally of Māori economic interests. The strategy was sophisticated and culturally specific: leverage the historical, economic, and cultural significance of tobacco in indigenous communities to resist the public health measures that would reduce consumption. The same companies that romanticized indigenous tobacco traditions in their marketing fought the policies that would protect indigenous people from their products.

The commercial tobacco industry's relationship with indigenous communities is further complicated by the role of tobacco sales in some indigenous economies. In the United States, tribal tobacco sales—cigarettes sold on reservations, often tax-free or at reduced tax rates—are a significant source of revenue for some tribal governments, funding healthcare, education, and infrastructure in communities with limited economic alternatives. The industry has exploited this dynamic, framing tobacco taxation and regulation as attacks on tribal sovereignty and economic self-determination. The result is a genuine tension, not manufactured by the industry, between the economic interests of some tribal governments and the health interests of tribal members. Resolving this tension requires economic development strategies that provide alternatives to tobacco revenue—a long-term project that the public health community has engaged with inconsistently and that the industry has actively undermined.

Indigenous-led tobacco control has charted a path that differs from mainstream approaches in important ways. Central to many indigenous cessation programs is the distinction between commercial tobacco (harmful, addictive, and alien to indigenous traditions) and sacred tobacco (ceremonial, medicinal, and integral to cultural practice). This distinction allows indigenous health advocates to promote cessation from commercial tobacco without rejecting the cultural role of tobacco entirely—a framing that's more culturally congruent and less stigmatizing than mainstream anti-tobacco messaging. Programs like Canada's 'Respecting Tobacco' and New Zealand's 'Aukati Kai Paipa' deliver cessation support through indigenous health workers, incorporate cultural practices and traditional healing, and address the social determinants of smoking (poverty, trauma, racism) alongside individual behavior change. These programs have achieved quit rates substantially higher than mainstream cessation services for indigenous populations, demonstrating that culturally grounded approaches are more effective than generic ones.

The harm-reduction dimension is particularly salient for indigenous populations, for whom complete nicotine abstinence may be less achievable—and less culturally relevant—than for settler populations. The distinction between commercial tobacco and sacred tobacco creates a conceptual space for non-combustible nicotine products (vaping, nicotine pouches) that deliver the addictive molecule without the combustion products that cause disease, and without the cultural baggage of commercial tobacco. Several indigenous health organizations have begun exploring harm-reduction approaches, including providing vaping products as an alternative to commercial cigarettes. This is controversial within indigenous communities (where some elders view any non-traditional nicotine use as problematic) and within mainstream public health (where harm reduction for indigenous populations raises concerns about industry exploitation). But the status quo—indigenous smoking rates at three times the general population, with corresponding mortality disparities—is not acceptable. Harm reduction deserves exploration, led by indigenous communities themselves, with appropriate safeguards against industry manipulation.

The indigenous smoking crisis is not separable from the broader project of indigenous health justice. It's embedded in the same colonial structures—land dispossession, economic marginalization, cultural suppression, intergenerational trauma—that drive every dimension of indigenous health disparities. Addressing smoking in indigenous communities requires addressing those structures, not just the individual behavior of smokers. It requires acknowledging that the commercial tobacco industry is a colonial industry, that its profits have been built on indigenous exploitation, and that indigenous communities have a right to determine their own relationship with tobacco—both the sacred plant that predates colonization and the commercial product that accompanied it. The path to health justice for indigenous peoples doesn't run through generic cessation messaging and nicotine patches. It runs through sovereignty, economic self-determination, and the right of indigenous communities to define what tobacco means to them—and to reject the version of it that's killing them.